Book contents
- Principles of Medicine in Africa
- Principles of Medicine in Africa
- Copyright page
- Contents
- Contributors
- Foreword
- Section 1 Health and Disease
- Section 2 Mother and Child Health
- Section 3 Infection: General Principles
- Section 4 Major Common Infections
- Section 5 Bacterial Infections
- Section 6 Viral Infections
- Section 7 Protozoal Infections
- Section 8 Helminth Infections
- Chapter 55 Intestinal Helminths
- Chapter 56 Schistosomiasis
- Chapter 57 Lymphatic Filariasis and Loiasis
- Chapter 58 Onchocerciasis
- Chapter 59 Cysticercosis and Neurocysticercosis
- Chapter 60 Echinococcosis (Hydatid Disease)
- Chapter 61 Paragonimiasis
- Chapter 62 Trichinellosis
- Chapter 63 Guinea Worm
- Section 9 Fungal Infections
- Section 10 Non-communicable Diseases
- Section 11 Diseases of Body Systems
- Section 12 Cancer and Palliative Care
- Section 13 Venoms and Poisons
- Index
- References
Chapter 57 - Lymphatic Filariasis and Loiasis
from Section 8 - Helminth Infections
Published online by Cambridge University Press: 18 June 2025
Book contents
- Principles of Medicine in Africa
- Principles of Medicine in Africa
- Copyright page
- Contents
- Contributors
- Foreword
- Section 1 Health and Disease
- Section 2 Mother and Child Health
- Section 3 Infection: General Principles
- Section 4 Major Common Infections
- Section 5 Bacterial Infections
- Section 6 Viral Infections
- Section 7 Protozoal Infections
- Section 8 Helminth Infections
- Chapter 55 Intestinal Helminths
- Chapter 56 Schistosomiasis
- Chapter 57 Lymphatic Filariasis and Loiasis
- Chapter 58 Onchocerciasis
- Chapter 59 Cysticercosis and Neurocysticercosis
- Chapter 60 Echinococcosis (Hydatid Disease)
- Chapter 61 Paragonimiasis
- Chapter 62 Trichinellosis
- Chapter 63 Guinea Worm
- Section 9 Fungal Infections
- Section 10 Non-communicable Diseases
- Section 11 Diseases of Body Systems
- Section 12 Cancer and Palliative Care
- Section 13 Venoms and Poisons
- Index
- References
Summary
Lymphatic filariasis (LF) is a major cause of long-term disability in African countries. Thanks to huge global efforts the prevalence of LF has been reduced from ~199 million in 2000 to ~51.4 million in 2018 (Local Burden of Disease Neglected Tropical Diseases, 2020). The WHO lists LF as a target for elimination as a public health problem till 2030.
Information
- Type
- Chapter
- Information
- Principles of Medicine in Africa , pp. 560 - 566Publisher: Cambridge University PressPrint publication year: 2025
References
Beng, A. A., Esum, M. E., Deribe, K. et al. 2020. Mapping lymphatic filariasis in Loa loa endemic health districts naive for ivermectin mass administration and situated in the forested zone of Cameroon. BMC Infect Dis, 20, 284.10.1186/s12879-020-05009-3CrossRefGoogle ScholarPubMed
Betts, H., Martindale, S., Chiphwanya, J. et al. 2020. Significant improvement in quality of life following surgery for hydrocoele caused by lymphatic filariasis in Malawi: a prospective cohort study. PLoS Negl Trop Dis, 14, e0008314.10.1371/journal.pntd.0008314CrossRefGoogle ScholarPubMed
Bockarie, M.J., Pedersen, E.M., White, G.B. & Michael, E. 2009. Role of vector control in the global program to eliminate lymphatic filariasis. Annu Rev Entomol, 54, 469–87.10.1146/annurev.ento.54.110807.090626CrossRefGoogle ScholarPubMed
Boussinesq, M. 2012. Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med, 19, 140–3.CrossRefGoogle ScholarPubMed
Boussinesq, M., Gardon, J., Gardon-Wendel, N. & Chippaux, J. P. 2003. Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J, 2 Suppl. 1, S4.10.1186/1475-2883-2-S1-S4CrossRefGoogle ScholarPubMed
Bowler, G. S., Shah, A. N., Bye, L. A. & Saldana, M. 2011. Ocular loiasis in London 2008–2009: a case series. Eye (Lond), 25, 389–91.10.1038/eye.2010.192CrossRefGoogle ScholarPubMed
Dietrich, C. F., Chaubal, N., Hoerauf, A. et al. 2019. Review of dancing parasites in lymphatic filariasis. Ultrasound Int Open, 5, E65–74.Google ScholarPubMed
Gardon, J., Gardon-Wendel, N., Demanga, N., Kamgno, J., Chippaux, J. P. & Boussinesq, M. 1997. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet, 350, 18–22.10.1016/S0140-6736(96)11094-1CrossRefGoogle Scholar
Hoerauf, A. 2008. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis, 21, 673–81.CrossRefGoogle ScholarPubMed
Kamgno, J., Pion, S. D., Chesnais, C. B. et al. 2017. A test-and-not-treat strategy for onchocerciasis in Loa loa-endemic areas. N Engl J Med, 377, 2044–2052.10.1056/NEJMoa1705026CrossRefGoogle ScholarPubMed
Local Burden of Disease Neglected Tropical Diseases 2020. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis. Lancet Glob Health, 8, e1186–e1194.10.1016/S2214-109X(20)30286-2CrossRefGoogle Scholar
MacKenzie, C. D. & Mante, S. 2020. Caring for patients in the global programme to eliminate lymphatic filariasis. Int Health, 13, S48–S54.10.1093/inthealth/ihaa080CrossRefGoogle ScholarPubMed
Mand, S., Debrah, A. Y., Klarmann, U. et al. 2012. Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Clin Infect Dis, 55, 621–30.CrossRefGoogle ScholarPubMed
Metais, A., Michalak, S. & Rousseau, A. 2021. Albendazole-related Loa loa encephalopathy. IDCases, 23, e01033.CrossRefGoogle ScholarPubMed
Pion, S. D., Montavon, C., Chesnais, C. B. et al. 2016. Positivity of antigen tests used for diagnosis of lymphatic filariasis in individuals without Wuchereria bancrofti infection but with high Loa loa microfilaremia. Am J Trop Med Hyg, 95, 1417–1423.10.4269/ajtmh.16-0547CrossRefGoogle ScholarPubMed
Simonsen, P. E., Fischer, P. U., Hoerauf, A. & Weil, G. J. 2014. The Filariases. In Farrar, J., Hotez, P. J., Junghanss, T., Kang, D., Lalloo, D. & White, N. J. (eds) Manson’s Tropical Diseases. 23rd ed. New York: Elsevier Saunders.Google Scholar
Taylor, M. J., Hoerauf, A. & Bockarie, M. 2010. Lymphatic filariasis and onchocerciasis. Lancet, 376, 1175–85.10.1016/S0140-6736(10)60586-7CrossRefGoogle ScholarPubMed
Taylor, M. J., Makunde, W. H., Mcgarry, H. F., Turner, J. D., Mand, S. & Hoerauf, A. 2005. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet, 365, 2116–21.10.1016/S0140-6736(05)66591-9CrossRefGoogle ScholarPubMed
Wanji, S., Akotshi, D. O., Mutro, M. N. et al. 2012. Validation of the rapid assessment procedure for loiasis (RAPLOA) in the Democratic Republic of Congo. Parasit Vectors, 5, 25.CrossRefGoogle ScholarPubMed
Wanji, S., Amvongo-Adjia, N., Njouendou, A. J. et al. 2016. Further evidence of the cross-reactivity of the Binax NOW(R) Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi. Parasit Vectors, 9, 267.10.1186/s13071-016-1556-8CrossRefGoogle Scholar
WHO 2017. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. Geneva: WHO.Google Scholar
Zouré, H. G., Wanji, S., Noma, M. et al. 2011. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for loiasis (RAPLOA). PLoS Negl Trop Dis, 5, e1210.10.1371/journal.pntd.0001210CrossRefGoogle ScholarPubMed
Accessibility standard: Unknown
Accessibility compliance for the PDF of this book is currently unknown
and may be updated in the future.